These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 24646729

  • 1. Comparability and imprecision of 8 frequently used commercially available immunoassays for therapeutic drug monitoring.
    Shipkova M, Petrova DT, Rosler AE, Orth M, Engelmayer J, Wieland E, Brandhorst G, Oellerich M.
    Ther Drug Monit; 2014 Aug; 36(4):433-41. PubMed ID: 24646729
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic drug monitoring on COBAS INTEGRA 400--evaluation results.
    Domke I, Cremer P, Huchtemann M.
    Clin Lab; 2000 Aug; 46(9-10):509-15. PubMed ID: 11034537
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic drug monitoring and drugs of abuse testing on the cobas 6000 analyzer series: analytical performance under routine-like conditions.
    Brandhorst G, Luthe H, Domke I, Knoke C, Rhode KH, Sauter H, Oellerich M.
    Clin Chem Lab Med; 2009 Aug; 47(7):854-9. PubMed ID: 19496737
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of Viva-E drug testing system].
    Chung HS, Lee ST, Lee SY.
    Korean J Lab Med; 2007 Oct; 27(5):330-7. PubMed ID: 18094597
    [Abstract] [Full Text] [Related]

  • 5. Analyses of the pattern of therapeutic drug monitoring in a university hospital laboratory. Suitability and performance of the CEDIA assays.
    Hänseler E, Bigler S, Wad N.
    Wien Klin Wochenschr Suppl; 1992 Oct; 191():23-6. PubMed ID: 1509748
    [Abstract] [Full Text] [Related]

  • 6. Performance characteristics of four immunoassays for antiepileptic drugs on the IMMULITE 2000 automated analyzer.
    Frank EL, Schwarz EL, Juenke J, Annesley TM, Roberts WL.
    Am J Clin Pathol; 2002 Jul; 118(1):124-31. PubMed ID: 12109846
    [Abstract] [Full Text] [Related]

  • 7. Effect of plantain on therapeutic drug monitoring of digoxin and thirteen other common drugs.
    Dasgupta A, Davis B, Wells A.
    Ann Clin Biochem; 2006 May; 43(Pt 3):223-5. PubMed ID: 16704760
    [Abstract] [Full Text] [Related]

  • 8. Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assay.
    Wallemacq P, Maine GT, Berg K, Rosiere T, Marquet P, Aimo G, Mengozzi G, Young J, Wonigeit K, Kretschmer R, Wermuth B, Schmid RW.
    Ther Drug Monit; 2010 Apr; 32(2):145-51. PubMed ID: 20216110
    [Abstract] [Full Text] [Related]

  • 9. Analytical validation of a quantitative method for therapeutic drug monitoring on the Alinity®c Abbott.
    Dubois N, Sqalli G, Gilson M, Charlier C.
    Ann Biol Clin (Paris); 2020 Apr 01; 78(2):147-155. PubMed ID: 32319943
    [Abstract] [Full Text] [Related]

  • 10. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay.
    Hermsen D, Apple F, Garcia-Beltràn L, Jaffe A, Karon B, Lewandrowski E, Mühlbacher A, Müller R, Ordóñez J, Pagani F, Panteghini M, Plecko T, Jarausch J.
    Clin Lab; 2007 Apr 01; 53(1-2):1-9. PubMed ID: 17323819
    [Abstract] [Full Text] [Related]

  • 11. PETINIA total phenytoin assay on the vista 1500 analyzer is not suitable for monitoring free phenytoin concentration if ultrafiltration is performed at room temperature.
    Dasgupta A, Everett JM, Davis B.
    Ther Drug Monit; 2013 Jun 01; 35(3):384-7. PubMed ID: 23666578
    [Abstract] [Full Text] [Related]

  • 12. Discordant results from "real-world" patient samples assayed for digoxin.
    Jones TE, Morris RG.
    Ann Pharmacother; 2008 Dec 01; 42(12):1797-803. PubMed ID: 19033482
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
    Sedman AJ, Molitoris BA, Nakata LM, Gal J.
    Am J Nephrol; 1986 Dec 01; 6(2):132-4. PubMed ID: 3085501
    [Abstract] [Full Text] [Related]

  • 14. Effect of heating sera under conditions necessary for deactivation of human immunodeficiency virus on commonly monitored therapeutic drugs.
    Dasgupta A, Bard D.
    Ther Drug Monit; 1994 Dec 01; 16(6):612-5. PubMed ID: 7878703
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of analytical methods and workflow performance of the Architect ci8200 integrated serum/plasma analyzer system.
    Hubl W, Zogbaum M, Boyd JC, Savory J, Schubert M, Meyer D, Demant T.
    Clin Chim Acta; 2005 Jul 01; 357(1):43-54. PubMed ID: 15963793
    [Abstract] [Full Text] [Related]

  • 16. CEDIA--homogeneous immunoassays for the 1990s and beyond.
    Coty WA, Loor R, Bellet N, Khanna PL, Kaspar P, Baier M.
    Wien Klin Wochenschr Suppl; 1992 Jul 01; 191():5-11. PubMed ID: 1509755
    [Abstract] [Full Text] [Related]

  • 17. Impact of interferences including metabolite crossreactivity on therapeutic drug monitoring results.
    Dasgupta A.
    Ther Drug Monit; 2012 Oct 01; 34(5):496-506. PubMed ID: 22846896
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of 2 immunoassays for monitoring low blood levels of tacrolimus.
    Amann S, Parker TS, Levine DM.
    Ther Drug Monit; 2009 Apr 01; 31(2):273-6. PubMed ID: 19142177
    [Abstract] [Full Text] [Related]

  • 19. Clinical evaluation of five therapeutic drugs using dry film multilayer technology on the OPUS immunoassay system.
    Jandreski MA, Shah JC, Garbincius J, Bermes EW.
    J Clin Lab Anal; 1991 Apr 01; 5(6):415-21. PubMed ID: 1774606
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of BD Barricor™ and PST™ blood collection tubes compared to serum for testing 11 therapeutic drugs on a Roche Cobas® 8000 platform.
    Jordan A, Sherazi A, Stevens A, Quondam Franks C, Sturgeon K, Northrup V, Shea JL.
    Clin Biochem; 2022 Feb 01; 100():60-66. PubMed ID: 34788637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.